Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
---|
06/01/2005 | CN1621402A Extraction and purification process of ferulic acid |
05/26/2005 | WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
05/26/2005 | US20050113454 Anti-viral compounds |
05/26/2005 | US20050113453 Development of new selective estrogen receptor modulators |
05/26/2005 | US20050113440 Compounds that modulate PPAR activity and methods for their preparation |
05/26/2005 | US20050113400 Novel benzophenone derivatives or salts thereof |
05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
05/25/2005 | CN1618785A Production technology of 2-methyl-4-chloro-sodium phenoxy acetate |
05/25/2005 | CN1203042C Preparation of optical pure D-malic acid |
05/24/2005 | US6897337 Labeling with methyl iodide |
05/24/2005 | CA2099162C Method and composition for inhibiting silica and silicate deposition |
05/19/2005 | WO2005044919A1 Mixture of fluorinated polyethers and use thereof as surfactant |
05/19/2005 | WO2005044773A1 Rare earth metal compound in aqueous solvent, method for producing same, and method for producing ceramic powder using same |
05/19/2005 | WO2005012233A8 Meldonium salts, method of their preparation and pharmaceutical composition on their basis |
05/19/2005 | WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor |
05/19/2005 | US20050107469 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
05/19/2005 | US20050107392 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
05/19/2005 | US20050107347 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
05/19/2005 | US20050107281 Ether carboxylic acids based on alkoxylated styrylphenols |
05/18/2005 | CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors |
05/18/2005 | CN1616411A Novel chiral amino acid derivative and its synthetic method and use |
05/18/2005 | CN1202103C Preparation method of red sageroot total phenolic acid |
05/18/2005 | CN1202068C Aspirin-triggered lipid mediators |
05/18/2005 | CN1202067C Method for preparing medicinal grade ferric citrate |
05/17/2005 | US6894190 Process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof |
05/17/2005 | US6894187 Method for producing a fluorine-containing compound |
05/17/2005 | US6894160 Converting sugars such as glucose and fructose into industrial useful products via hydrogenation and reductive amination using platinum catalyst formed from stabilized nanoparticles |
05/12/2005 | WO2005042509A1 7-`(7-alkoxy)-chrom-3-en-6-yl!-heptatrienoic acid and 7-`(3alkoxy)-5,6-dihydronaphthalen-2-yl!-heptatrienoic acid derivatives modulators |
05/12/2005 | WO2005042478A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
05/12/2005 | WO2005041946A1 Development of new selective estrogen receptor modulators |
05/12/2005 | WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators |
05/12/2005 | CA2539446A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
05/11/2005 | EP1528909A1 Trihydroxy polyunsaturated eicosanoids |
05/11/2005 | CN1200703C Use of pentanoate derivant |
05/10/2005 | CA2303801C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
05/06/2005 | WO2005040246A1 Acyloxy acetic acid polymer and method for producing same |
05/06/2005 | WO2005040104A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
05/06/2005 | CA2538630A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
05/05/2005 | US20050096480 Novel process for producing 1,2-diol |
05/05/2005 | US20050096380 For therapy of diabetes |
05/05/2005 | US20050096244 Mixture of fluorinated polyethers and use thereof as surfactant |
05/04/2005 | EP1527034A1 A process for the optical resolution of a precursor of sclareolide |
05/04/2005 | CN1612852A Lipoxin A4 analogs |
05/04/2005 | CN1612729A 2-aryl-propionic acid and medicine composition containing same |
05/04/2005 | CN1611479A Oxy-carbonyl compound for activating bleaching agent and bleachcing agent composition containing same |
05/03/2005 | US6888033 Contacting picornavirus with 2,6-dihydroxy acetophenone or its salt to inhibit replication of picornavirus |
05/03/2005 | US6887901 Lipoxin compounds and their use in treating cell proliferative disorders |
05/03/2005 | US6887896 7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity |
04/28/2005 | WO2005037763A1 Phenoxyether derivatives as ppar modulators |
04/28/2005 | US20050090555 Compound for the treatment of metabolic disorders |
04/28/2005 | US20050090484 Purification of natural, synthetic or semi-synthetic crude harringtonines by reverse phase chromatography and crystallization; solvent is water or lower alkanol, or an aqueous mixture of organic solvents; enantiomerically pure; industrial scale; leukemia chemotherapy |
04/28/2005 | CA2541751A1 Phenoxyether derivatives as ppar modulators |
04/27/2005 | EP1525177A1 Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
04/27/2005 | EP1370513B1 Malic acid addition salts of terbinafine |
04/27/2005 | CN1198782C Pure beta-hydroxyethoxyacetic acid salt, pure 2-p-dioxaneone, and prodn. method thereof |
04/26/2005 | US6884821 Alkyloxypropanoic acid derivative containing sulfonamide or amide group are useful as insulin resistance agent |
04/26/2005 | US6884820 Antidiabetic agents; side effect reduction |
04/26/2005 | CA2053253C New aryl-and heteroarylethenylene derivatives and process for their preparation |
04/21/2005 | WO2005023741A3 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives |
04/21/2005 | WO2004098582A3 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
04/20/2005 | EP1173400A4 Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars |
04/20/2005 | EP1165495B1 Resorcinol derivatives |
04/20/2005 | EP1089968B1 Thyroid hormone analogues and methods for their preparation |
04/20/2005 | EP0766669B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
04/20/2005 | CN1608093A Crystalline polyglycolic acid, polyglycolic acid composition and production process thereof |
04/20/2005 | CN1608055A Compounds for the treatment of metabolic disorders |
04/14/2005 | WO2005033056A2 Triphenylethylene compounds as selective estrogen receptor modulators |
04/14/2005 | US20050080291 Contiuous direct synthesis from perfluoroolefins or ketones and carbonyl fluoride; haloacylation catalyst of CsF, RbF, KF, or AgF on porous support; improved selectivity and yield |
04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
04/13/2005 | CN1605583A Process for removing tropina of 2-keto-L-guleonic acid fermentation liquid |
04/12/2005 | CA2157038C Plant growth promoter |
04/07/2005 | WO2005030972A1 Process for producing 3-hydroxypropionaldehyde |
04/07/2005 | WO2005030694A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
04/07/2005 | CA2539403A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
04/06/2005 | EP1519909A1 Polyene carboxylic acid derivatives, method for their production and the use thereof |
04/06/2005 | EP1519908A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
04/06/2005 | CN1603298A Process for extracting lactic acid from fermentation liquid |
04/06/2005 | CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
04/06/2005 | CN1602762A Novel souring agent |
04/06/2005 | CN1195413C Flower initiation inducer |
04/05/2005 | US6875780 Compounds that modulate PPAR activity and methods for their preparation |
04/05/2005 | US6875775 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
03/31/2005 | US20050070583 Novel compounds, their preparation and use |
03/30/2005 | EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma |
03/30/2005 | EP1436007B1 Compounds for use as surfactants |
03/30/2005 | CN1602298A Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
03/30/2005 | CN1602291A Novel bensophenone derivatives or salts thereof |
03/30/2005 | CN1194674C Novel diphenylethylene compounds |
03/24/2005 | WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor |
03/24/2005 | WO2004099279A3 Heat activated tertiary amine urethane catalysts |
03/24/2005 | WO2004071426A3 Compounds for the treatment of viral infection |
03/24/2005 | US20050063999 Use of at least one (dihydro)jasmonic acid derivative as a desquamating agent |
03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
03/24/2005 | CA2539366A1 Process for the production of alpha-alkoxy/hydroxy-beta-(p-hydroxyphenyl) propionic acid derivatives |
03/23/2005 | EP1091924A4 Novel retinoids and use thereof |
03/22/2005 | CA2168514C Isocarbacyclin derivatives |
03/17/2005 | WO2005023741A2 Pharmaceutical compositions containing (+) cannabidiol and derivatives thereof and some such novel derivatives |
03/17/2005 | WO2005023267A1 Cyclohexyl prostaglandin analogs as ep4-receptor agonists |